scispace - formally typeset
N

Nan Lin

Researcher at Harvard University

Publications -  1220
Citations -  65601

Nan Lin is an academic researcher from Harvard University. The author has contributed to research in topics: Medicine & Breast cancer. The author has an hindex of 105, co-authored 687 publications receiving 54545 citations. Previous affiliations of Nan Lin include University of Michigan & Fujian Medical University.

Papers
More filters
Proceedings ArticleDOI

Cost Savings & Predictable Performance Benefits of Carbon Nanotube Satellite Thermal Interface Solutions

TL;DR: In this paper , the authors present an analysis of the cost savings and performance benefits delivered by a predictable carbon-nanotube-based thermal gasket -Carbice® Space Pad™, for spacecraft builds, showing a >60% net savings in the Assembly Integration & Test (AI&T) and Thermal cost in a typical satellite build, supported by an independent analysis performed by a large space prime.
Journal ArticleDOI

A gold nanoparticle engineered metal-organic framework nanoreactor for combined ferroptosis and mild photothermal therapy.

TL;DR: In this paper , a gold nanoparticle engineered metal-organic framework nanoreactor with photothermal, glucose oxidase-like and GSH consuming performance was demonstrated to achieve the accumulation of hydroxyl radicals and enhancement of the thermal sensitivity for combined ferroptosis and mild photothermal therapy.
Journal ArticleDOI

Do Children With an Allergic Transfusion Reaction Require Premedication For All Blood Products?

TL;DR: A retrospective chart review of children who received blood product transfusions (packed red blood cells, platelets, frozen plasma, intravenous immunoglobin, albumin, and cryoprecipitate) and developed ATRs was performed in this article .
Journal ArticleDOI

An overview of thrombin inhibitors in the perspective of structure-activity relationships.

TL;DR: Recent advances on the newly synthesized and isolated thrombin inhibitors from 2000 to 2019 and their structure-activity relationships (SARs) along with structure-dependent pharmacokinetic parameters are summarized, providing guidance for next generation of oral thromin inhibitors.
Journal ArticleDOI

New Process Combining Fe-Based Chemical Looping and Biomass Pyrolysis for Cogeneration of Hydrogen, Biochar, Bio-Oil and Electricity with In-Suit CO2 Separation

TL;DR: In this article , a novel process combining Fe-based chemical looping and biomass pyrolysis was proposed and simulated using Aspen Plus, which has the advantage of reducing CO2 emissions and the potential of self-sustaining operation without supplemental heating.